GPFA
LSTA icon

Game Plan Financial Advisors’s Lisata Therapeutics LSTA Stock Holding History

Game Plan Financial Advisors’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,133
Closed -$21K – 112
2021
Q3 		$21K Sell
1,133
-534
-32% -$10.5K 0.01% 103
2021
Q2 		$40K Buy
1,667
+667
+67% +$15.8K 0.02% 98
2021
Q1 		$29K Buy
+1,000
New +$30.3K 0.02% 99

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Game Plan Financial Advisors's LSTA Position: Q4 2021 in Review

Game Plan Financial Advisors sold out of Lisata Therapeutics (LSTA) in Q4 2021, closing a stake of 1,133 shares — an estimated $21K sold.

Game Plan Financial Advisors first reported a position in LSTA in Q1 2021 and held it in 3 quarters. The position peaked at $40K in Q2 2021. 34 funds tracked by Wall St. Rank hold LSTA as of Q4 2021.

  • Game Plan Financial Advisors reported no remaining Lisata Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Game Plan Financial Advisors sold 1,133 Lisata Therapeutics shares in Q4 2021, an estimated $21K.
  • Game Plan Financial Advisors first reported a position in Lisata Therapeutics in Q1 2021 and held it in 3 quarters.
  • Game Plan Financial Advisors's Lisata Therapeutics position peaked at $40K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2021.

Based on Game Plan Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.